Sk Life Science, Inc.

This study is testing whether the approved drug cenobamate can effectively control seizures when used alone in adults with focal epilepsy. It will enroll 49 adults who are either newly diagnosed or have had seizures return, and will measure how many can stay seizure-free for 26 w…

This study aims to check the long-term safety of the seizure medication cenobamate over one year. It is for 145 people with generalized tonic-clonic seizures who finished a previous core study. Participants will take cenobamate daily, with doses adjusted as needed, while doctors …